Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-002532
Filing Date
2015-03-20
Accepted
2015-03-20 16:03:34
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223659z10-k.htm 10-K 1412402
2 EX-10.7 a2223659zex-10_7.htm EX-10.7 123434
3 EX-10.9 a2223659zex-10_9.htm EX-10.9 331564
4 EX-23.1.1 a2223659zex-23_11.htm EX-23.1.1 3004
5 EX-31.1.1 a2223659zex-31_11.htm EX-31.1.1 8207
6 EX-31.2.1 a2223659zex-31_21.htm EX-31.2.1 8209
7 EX-32.1.1 a2223659zex-32_11.htm EX-32.1.1 5438
14 G254360.JPG g254360.jpg GRAPHIC 61594
  Complete submission text file 0001047469-15-002532.txt   15352455

Data Files

Seq Description Document Type Size
8 EX-101.INS osir-20141231.xml EX-101.INS 3052180
9 EX-101.SCH osir-20141231.xsd EX-101.SCH 66029
10 EX-101.CAL osir-20141231_cal.xml EX-101.CAL 84780
11 EX-101.LAB osir-20141231_lab.xml EX-101.LAB 690626
12 EX-101.PRE osir-20141231_pre.xml EX-101.PRE 462408
13 EX-101.DEF osir-20141231_def.xml EX-101.DEF 221090
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 15716344
SIC: 2836 Biological Products, (No Diagnostic Substances)